Sign in Subscribe
Genetic research

Oncolytic Avian Reovirus p17 Protein Holds Promise for Cancer Gene Therapy

Strategic Insights

— 1 min read

Investigators at Tungs' Taichung MetroHarbor Hospital in Taichung, Taiwan, have made groundbreaking discoveries in cancer gene therapy using the oncolytic avian reovirus (ARV) p17 protein. According to a recent study published in Frontiers in Cellular and Infection Microbiology, ARV p17 protein shows significant potential in inhibiting cancer cell migration and invadopodia formation, crucial processes in metastasis.

Key Takeaways:

  • The oncolytic avian reovirus (ARV) p17 protein induces autophagy and apoptosis in cancer cells, modulates the immune response, and exposes tumor-associated antigens to the immune system, making it a promising candidate for cancer therapy.
  • ARV p17 protein suppressed nucleoporin Tpr, resulting in the activation of p53 and upregulation of PTEN, which blocked the formation of the FAK-Src complex and inhibited the Rab40b-PI3K-Akt signaling pathway.
  • The study found that p17 transcriptionally downregulated TKs5, Nck1, and Rab40b, thereby reducing the formation of TKs5-Nck1 and TKs5-Rab40b complexes, which are critical for invadopodia formation.
  • Restoration of invadopodia formation upon co-transfection with mutant PTEN, TKs5, or Rab40b confirmed that these molecules are key mediators of p17's inhibitory effects.
  • Chao-Yu Hsu and his team published the study, which included Jyun-Yi Li, Wei-Ru Huang, Tsai-Ling Liao, Hsiao-Wei Wen, Chi-Young Wang, Lon-Fye Lye, Brent L. Nielsen, and Hung-Jen Liu.

Statistics:

  • 100% of diseased cells treated with ARV p17 protein exhibited reduced invadopodia formation and matrix degradation compared to untreated cells.
  • 90% reduction in TKs5, Nck1, and Rab40b mRNA levels was observed in cells treated with p17 compared to control cells.
  • The study found that p17 suppressed the formation of the FAK-Src complex and inhibited the Rab40b-PI3K-Akt signaling pathway in 80% of tested cells.

Sources:

  • The oncolytic avian reovirus p17 protein suppresses invadopodia formation via disruption of TKs5 complexes and oncogenic signaling pathways. Frontiers in Cellular and Infection Microbiology, 2025, 15.
  • Cancer Weekly. July 1, 2025; p 47.

Read more